What is it about?
Cranial Dural arteriovenous fistula (dAVF) account for approximately 10% of all intracranial vascular malformations. While they can benign lesions, the presence of retrograde venous drainage and cortical venous reflux makes the natural course of these lesions aggressive high risk of hemorrhage, neurological injury, and mortality. Endovascular treatment is often the first-line of treatment for dAVF. Both transarterial and transvenous approaches are used to cure dAVF. The selection of treatment approach depends on the angioarchitecture of the dAVF, the location, the direction of venous flow. Surgery and, to a lesser extent, stereotactic radiosurgery (SRS) are often utilized when endovascular approaches are impossible or unsuccessful.
Featured Image
Read the Original
This page is a summary of: Updates in the management of cranial dural arteriovenous fistula, Stroke and Vascular Neurology, November 2019, BMJ,
DOI: 10.1136/svn-2019-000269.
You can read the full text:
Contributors
Be the first to contribute to this page







